Log in
Enquire now
‌

US Patent 11976026 Amphetamine carbamate compounds and methods

Patent 11976026 was granted and assigned to Noven Pharmaceuticals on May, 2024 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors
Is a
Patent
Patent
0
Current Assignee
Noven Pharmaceuticals
Noven Pharmaceuticals
0
Date Filed
January 18, 2023
0
Date of Patent
May 7, 2024
0
Patent Applicant
Noven Pharmaceuticals
Noven Pharmaceuticals
0
Patent Application Number
18098416
0
Patent Citations
‌
US Patent 8815281 Transdermal drug delivery device including an occlusive backing
0
‌
US Patent 9155712 Transdermal drug delivery device including an occlusive backing
0
‌
US Patent 9333263 Device for transdermal administration of drugs including acrylic based polymers
0
‌
US Patent 9456993 Compositions and methods for transdermal delivery of amphetamine
0
‌
US Patent 9474722 Compositions and methods for transdermal delivery of amphetamine
0
‌
US Patent 9901552 Compositions and methods for transdermal delivery of amphetamine
0
‌
US Patent 10004696 Compositions and methods for transdermal delivery of amphetamine
0
‌
US Patent 10231938 Transdermal drug delivery device including an occlusive backing
0
‌
US Patent 10406115 Pressure-sensitive adhesives for transdermal drug delivery
0
‌
US Patent 10406116 Pressure-sensitive adhesives for transdermal drug delivery
0
•••
Patent Inventor Names
Deboprosad Mondal
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
11976026
0
Patent Primary Examiner
‌
Daniel S Larkin
0

Find more entities like US Patent 11976026 Amphetamine carbamate compounds and methods

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.